A B S T R A C T Cholesterol4-'C was injected intravenously into a series of normal men, untreated hyperlipidemic patients, and hyperlipidemic patients being treated with cholestyramine. The specific radioactivity of plasma total cholesterol was measured during the ensuing 10 wk. 16 studies were carried out in 10 subjects. Analysis of the turnover curves of plasma cholesterol revealed that in every study the turnover of plasma cholesterol conformed to a two-pool model. Each turnover curve was analyzed in terms of this model, as expressed by the equation: specific activity = CAe-at + CBeA0. The parameters which were calculated included the constants CA, CB, a, and 8; the size of the first pool (MA); the rate constants for the total rate of removal of cholesterol from each pool (kA and kBB); and the production rate in pool A (PRA). In two normal men and five untreated patients the average size of pool A-was 25 g.
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The effect of cholestyramine was assessed by comparing the results obtained without therapy with those obtained during therapy in five subjects studied under both conditions. Cholestyramine therapy produced a large increase in PRA (from 0.98 to 1.98 g/day) and in the rate of removal of cholesterol from pool A. Cholestyramine did not significantly alter the size of pool A.
It is not possible to calculate the size of the total body exchangeable pool of cholesterol from the turnover curve of plasma cholesterol. It is also not possible to calculate the metabolic turnover rate,
INTRODUCTION
The turnover of plasma cholesterol in man has been studied repeatedly during the past few years (2) (3) (4) (5) (6) (7) . In these studies, isotopically labeled cholesterol (3, 4, 6, 7) or a biosynthetic precursor of cholesterol (5) was injected intravenously, and the specific radioactivity of plasma cholesterol was then determined during the ensuing weeks. These studies demonstrated that, after isotope administration, the semilogarithmic plot of cholesterol specific radioactivity vs. time describes a curve during the first 4-6 wk. whereas beyond this time the plot is linear. The changing slope of the curve during the first few weeks has been shown to be due to slow rates of equilibration between the cholesterol pools of plasma and various tissues (8, 9) . Thus, postmortem analyses of tissues of patients who received labeled cholesterol from 1 to 226 days (9) or from 2.5 to 137 days (8) before death demonstrated that complete equilibration between plasma and tissue cholesterol required up to a month for some tissues, and more than a month for arteries. Once equilibration between plasma and tissue cholesterol was achieved, however, it was maintained indefinitely. The cholesterol in all tissues except brain was found to equilibrate with plasma cholesterol (9) . On the basis of these results, it has usually been assumed that the late, linear portion of the plasma cholesterol turnover curve reflects the turnover of the total body pool of exchangeable cholesterol. Accordingly, in some studies estimates of the turnover of total body cholesterol and of the size of the total body miscible pool of cholesterol have been derived from turnover curves of plasma cholesterol.
The studies reported here were undertaken as part of an extensive investigation on the effects of cholestyramine on the metabolism of plasma lipids. In these studies, 14C-labeled cholesterol was injected intravenously into a series of normal men, untreated hyperlipidemic patients, and hyperlipidemic patients being treated with cholestyramine. Analysis of the curves of plasma cholesterol specific radioactivity vs. time revealed that in every instance the turnover of plasma cholesterol conformed to a two-pool model. The purpose of this paper is to present the results of these studies and to discuss in detail the interpretation of plasma cholesterol turnover curves.
METHODS
10 volunteer subjects, whose ages and sexes are given in Table I , participated in these studies. Two of the subjects (R.N. and R.O.) served as normal controls. The other eight subjects all had mild to moderate degrees of hyperlipidemia (see Table I ). Seven of the hyperlipidemic patients (all except H.D.) had clinical coronary heart disease, as indicated by the presence of angina pectoris, or by the past history of documented myocardial infarction. All subjects ate their usual diets throughout the studies. None of the subjects lost or gained significant amounts of weight during the periods of study.
16 turnover studies were carried out in two series (study series I and II), separated by an interval of 1 yr. In study series I, three untreated patients and five patients being treated with cholestyramine (Questran, Mead Johnson & Co.) were injected intravenously with cholesterol-"4C. In study series II, two normal controls, two untreated patients, three patients being treated with cholestyramine, and one patient taking ethyl fr-chlorophenoxyisobutyrate (CPIB, clofibrate; Atromid-S, Ayerst Laboratories) were studied in a similar fashion. Cholestyramine was administered at a level of 12 g/day, and CPIB at a dose of 2 g/day. All subjects studied during periods of drug treatment had taken the drug for 3 or more months before isotope injection. All subjects had stable plasma cholesterol and triglyceride levels for several .weeks before the start of each study and throughout the period of each study. As indicated in Table I , six of the subjects were studied, under different circumstances, in both study series I and II.
In each study series, 500 AC of cholesterol-4-14C (New England Nuclear Corp., Boston, Mass.; specific radioactivity 56 ,uc/,mole) was dissolved in 0.5 ml of acetone, and the acetone solution was then injected slowly, via a 100 I, syringe, beneath the surface of 30 ml of serum.
The serum was freshly drawn from one of the investigators earlier in the day and was gently swirled during the period of acetone addition. The labeled serum was shaken gently at 370C for 2 hr and at room temperature for an additional 16 to 20 hr. The serum was then sterilized by passage through a Millipore filter of pore size 0.2 1A.
Serum containing approximately 30 
RESULTS
Analysis and discussion of plasma cholesterol turnover curves. Fig. 1 shows the results obtained after injecting cholesterol-14C into normal control subject R.N'. The semilogarithmic plot of specific radioactivity vs. time described a curve during the first 5 wk, whereas from 6 wk onward the plot followed a straight line. Similar curves were obtained in all of the studies which we have carried W E E K S out; in every study a constant exponential rate of fall was achieved after 5 or 6 wk. Each turnover curve was analyzed in order to determine the number of kinetically distinguishable pools (compartments) involved in the turnover of plasma cholesterol in man. As shown in Fig. 1 , this analysis was done by extrapolating the terminal linear portion of the turnover curve back to zero time. From each experimental point measured during the first 5 wk the value of the corresponding point on the extrapolated line was then subtracted, and the difference values so obtained were plotted semilogarithmically. As shown in Fig. 1 , the plot of the difference between the experimental points and the extrapolated line described a straight line, indicating that the turnover of plasma cholesterol conformed to a two-pool model (12. 13) . If more than two kinetically distinguishable pools had been involved in the turnover of plasma cholesterol, the first portion of the plot of the difference would have described a curve rather than a straight line, and it would have been necessary to continue the process of subtraction in order to determine the number of pools involved.
Similar analyses were carried out in each of the . line. 9 10 16 studies resported here. In every instance the results conformed to a two-pool mo(lel.
A detailed discussion of the kinetic analysis of two-pool systems was recently reported by Gurpide, Mann, and Sandberg (13) . As noted l)y these workers, the general two-pool system can be described by the model shown in Fig. 2 tion satisfactorily characterize turnover curves of plasma cholesterol in man, such as the one shown in Fig. 1 . A number of kinetic and other parameters can be determined from a plasma cholesterol turnover curve such as that shown in Fig. 1 (see reference 13 for a complete discussion). First of all, the y-intercepts of the two straight lines directly provide the values of the constants CA and CB in equation (1) (see Fig. 1 ). Second, the constants a and f3 can be directly calculated from the slopes of the two straight lines. Thus the values of these constants are determined from the half-lives of the two exponentials, since a = in 2/t1 = 0.69315/t4 (of the first exponential), and 8 = in 2/t1 (of the second exponential). Third, the size of the first pool (pool A) can be calculated as follows:
(2) CA + CB where MA = the size of pool A, and RA = the amount of isotope injected into pool A. Fourth, the rate constants for the total rate of removal of cholesterol from pool A (kAA) and from pool B (kBB) can be calculated as follows:
Finally, it is possible to calculate the production rate of cholesterol in pool A (PRA). The production rate in a given pool has been said to represent the rate of entry of material into the pool, excluding recycled material originating in that pool (13, 14) . For the turnover of plasma cholesterol, using the two-pool model under discusion: PRA = R-aO (;5) aCB + INCA As indicated by Gurpide et al. (13) , other parameters describing the two-pool model (Fig. 2 ) cannot be derived from turnover curves of the type shown in Fig. 1 . It is, for example, not possible to determine the size of the second pool (pool B) except for the very special case where either sA and kA both equal zero, or SB and kB both equal zero. It is extremely unlikely that these special conditions apply to the turnover of cholesterol (see Discussion). It is hence not possible to determine the size of the total body exchangeable cholesterol (pool A + pool B) from these turnover data. It is also not possible to determine precisely the values of the individual rate constants shown in Fig. 2 , except for the special case where either kA or kB equals zero. If, however, one assumes that kB approximates zero, then kIBA = -kBB; kA =af/kBA; and kAB =-kAA-kA (see reference 13 for derivations).
Experimental results. Table I presents the values for each of the several parameters discussed above for each of the 16 turnover studies carried out. It should be noted that the actual, experimentally obtained turnover curves can readily be constructed from the values of CA, C11. and the half-lives of the two exponentials.
Computer calculations. The results presented in Table I were obtained by the hand fitting of the data from each study to a sum of two exponentials. In order to evaluate the precision of these results, the data obtained in six of the 16 studies were also subjected to compartmental analysis by a digital computer, as described by Berman and his colleagues (12, (15) (16) (17) Table II ). The computer analysis also confirmed the fact that the two-compartment model provides an excellent fit for the data o1tained in these studies. * The values listed represent the best value for each parameter, as determined by a least squares solution, together with the standard deviation for each parameter. The values of CA, CB, a, and is were determined by analyzing the data in terms of a two-pool exponential as described by equation (1) . The rate constants (kBA, kA, and kAB) were calculated independently of the values obtained for CA, CB, a, and is, by using a two-compartment model in which kB = 0. tients in whom administration of cholestyramine at a dose of 12 g/day produced an average decrease of 13%o in the plasma cholesterol level, whereas a dose of 24 g/day produced an average decrease of 20%o (R. P. Noble, unpublished observations). (18) . NS means that the effect of therapy was not significant (P values given in parentheses). PS means that the effect of therapy was statistically probably significant (0.01 < P < 0.05), aild SS means that the effect was statistically significant (P < 0.01). $ Calculated by assuming that kE = 0. exponential, but was not statistically significant (0.1 < P < 0.2) for the second exponential. 1 The effect of cholestyramine on the turnover of plasma cholesterol is shown graphically in Fig. 3 , which presents the mean curves obtained both off and on therapy for the five subjects studied under both conditions. One subject-(E.M.) was studied first during a period of cholestyramine therapy and subsequently while being treated with CPIB. In this 1 Additional information about the kinetic parameters involved in the model for cholesterol turnover and about the effect of cholestyramine can be obtained by postulating that the change produced in the system by therapy is limited to one or two parameters. This approach to the effect of a "perturbation" on a model has been discussed by Berman (19) . If, for example, one assumes that cholestyramine therapy does not alter the values of the rate constants kAB, kBA, or kB, it is possible to obtain ranges for the values of all the rate constants shown in Fig. 2 (kAB, kBA, kA, and kB) for the complete model where kB is not assumed to equal zero. Computer analysis (kindly carried out by Dr. Frank) of the data of subjects H.D., L.L., and L.P. indicated that the data were consistent with a model which assumes that kB equals zero and that cholestyramine therapy does not alter the values of kAB and kBA. subject, the results (Table I) pared to hyperlipidemic subjects. With the data on hand, the only parameter which was significantly different for the normal as compared to the hyperlipidemic subjects was CB (0.02 < P < 0.05).
DISCUSSION
In the studies reported here, compartmental analysis of the turnover curves of plasma cholesterol indicated that the turnover of plasma cholesterol in man can be described by a two-pool model. This was true for every one of the 16 studies which we have conducted in normal men, in untreated hyperlipidemic patients, and in hyperlipidemic patients being treated with cholestyramine or CPIB. It is of interest that Avigan, Steinberg, and Berman likewise observed that the turnover of serum cholesterol in the rat could be described by an equation for a two-compartment system (20) . In contrast, Casdorph et al. reported that the turnover of plasma cholesterol in dogs was best fitted by a four-compartment system (21) .
In discussing the turnover of plasma cholesterol in terms of a two-pool model, it must be clearly recognized that the pools in question (see Fig. 2 ) represent mathematical constructs and do not have precise physical meaning. It is now well established that the in vivo turnover of cholesterol in man involves a large number of metabolically heterogeneous pools of cholesterol in different tissues and within given tissues (8, 9, 22, 23) . Even within plasma itself, four metabolically heterogeneous pools of cholesterol (free cholesterol, and ester cholesterol in each of three plasma lipoprotein fractions) have been distinguished (23) . The finding that the turnover of plasma total cholesterol conforms to a two-pool model hence means that the various tissue pools of cholesterol fall into two groups in terms of the rates at which they equilibrate with plasma cholesterol. One group of pools is apparently in fairly rapid equilibrium (in terms of hours to days) with plasma cholesterol, whereas the second group of pools is in fairly slow equilibrium (in terms of days to weeks) with plasma cholesterol. Within each group, the rates of equilibration of the different pools with plasma cholesterol are apparently sufficiently similar so that the group behaves as a single pool, when analyzed in terms of the turnover curve of plasma total cholesterol. in the present studies, all of the data, for samples collected from 8 hr to 10 wk after isotope injection, conformed precisely to a two-pool model. (Fig. 2) . As discussed above, the parameters which can be determined include the constants CA, Cal, a, and fi3 (see equation 1), the size of the first pool (MA), the rate constants for the total rate of removal of cholesterol from each pool (kAA an(l kBB), and the production rate in pool A (PRA) (see reference 13 for complete discussion). An important parameter which cannot be derived from the plasma cholesterol turnover curve is the size of the second pool, pool B. Gurpide et al. (13) have indicated that the size of the second pool can only be determined when either SA and kA or sB an(l k1l both equal zero. Since the liver and the intestine are the major organs involved in cholesterol biosynthesis, it is certain that SA does not equal zero. It is also highly unlikely that sly equals zero, since it is well established that virtually all organs and tissues are capable of carrying out cholesterol biosynthesis (27) (28) (29) . The special conditions which may permit the calculation of the size of the second pool therefore do not apply to cholesterol turnover. Accordingly, it is not possible to calculate the size of the total body exchangeable pool of cholesterol from the turnover curve of plasma cholesterol.
Another parameter which cannot be determined in the general two-pool model (Fig. 2) is the metabolic turnover rate of cholesterol (that is, the rate of cholesterol degradation and excretion) in the whole body. Several previous studies of cholesterol turnover in man have estimated the total metabolic turnover rate of cholesterol by assuming that the late, linear portion of the plasma turnover curve represents the half-life of the total body miscible cholesterol. This procedure is not correct (13, 30) since the slope of the late, linear portion of the turnover curve (a measure of 8 in equation 1 ) has no precise physical meaning and is a complex mathematical function of all of the rate constants shown in Fig. 2.2 The metabolic turnover rate of cholesterol can, however, be calculated by assuming that kB, the rate of removal of cholesterol from the system directly via pool B, al)proximates zero. This assumption seems reasonable since there is probably only a quantitatively unimportant amount of cholesterol degradation and excretion directly via the peripheral tissue and organ pools which comprise pool B. The known quantitatively important pathways of cholesterol metabolism include the catabolism of cholesterol to bile acids in the liver and the excretion of acidic steroids and neutral sterols via the feces (7, (31) (32) (33) . The fecal sterols and sterol metabolites originate mainly in the liver and also partly in the intestinal mucosa. It has also been suggested recently that a variable amount of sterol ring degradation and loss occurs in the intestinal lumen (34) . It seems likely that these pathways of cholesterol degradation and excretion originate almost completely in tissue pools which comprise pool A.
As noted above, by assuming that kB equals zero it is possible to calculate kA, kBA, and kAB. By combining kA, the rate constant for the direct 2 The constants a and f8 can be expressed as quadratic functions of the rate constants kAA, kBB, kAB, and kBA.
These functions can readily be derived from the following expressions: a + ,8 =-(kAA + kBB); and ale = kAAkBB -kAnkB.-removal of cholesterol from pool A (and hence from the system, since kB = 0), with the size of pool A, the metabolic turnover of cholesterol from the body, in grams per day, can be calculated readily. This calculation can be omitted, however, since it is evident from inspection of Fig. 2 that the rate of cholesterol entry into and loss from the system (i.e., the metabolic turnover rate) is identical with the production rate in pool A for the special case where kB equals zero. This is, of course, true only in the steady state. The production rate in pool A, calculated according to equation (5), hence should provide a valid measurenment of the rate of cholesterol degradation and excretion in the whole body. The validity of this interpretation of PRA depends, of course, on the correctness of the assumption that kB equals zero. Future studies, comparing the production rate with the rate of cholesterol turnover as measured by total balance methods, will be necessary in order to determine whether or not the production rate provides a valid estimate of the metabolic turnover rate of cholesterol.
The studies presented here illustrate the information which can be obtained by a two-pool compartmental analysis of the turnover of plasma cholesterol in man. In both normal and hyperlipidemic subjects, the first pool (pool A) was found to contain approximately 25 g of cholesterol, and the values of a and fB were found to be approximately 0.13 and 0.015, respectively. The mean value for the production rate in pool A was 0.98 g/day for the hyperlipidemic and 1.35 g/day for the normal subjects. Treatment with cholestyramine minimally affected the size of pool A, decreased the half-lives of both exponentials to a small extent, and greatly increased the production rate in pool A and the rate of removal of cholesterol from pool A. If we assume that the production rate provides a valid estimate of the metabolic turnover rate, then these results indicate that cholestyramine produces a 100% increase in the rate of cholesterol degradation and excretion from the body. 
